Literature DB >> 10215287

Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.

P Turrini1, A Angelini, G Thiene, G Buja, L Daliento, G Rizzoli, A Nava.   

Abstract

We studied 38 patients (mean age 32 +/- 14 years) with arrhythmogenic right ventricular cardiomyopathy (ARVC) to evaluate the clinical significance of histologic features on endomyocardial biopsy specimens as related to signal-averaged electrocardiography (SAECG), spontaneous ventricular arrhythmias, and hemodynamic features. Fifteen patients presented with ventricular tachycardia or fibrillation (sustained ventricular arrhythmias), 23 with other minor arrhythmias. SAECG variables and right ventricular ejection fraction (RVEF) were statistically correlated with the extent of myocardial fibrosis on biopsy in ARVC. An increased percentage of fibrous tissue (> or = 30%) was a significant univariate predictor of late potentials (p = 0.004) and reduced RVEF (p = 0.02). The 18 patients with late potentials had an increased percentage of fibrous tissue (p = 0.01), a reduced RVEF (p = 0.0004), and a higher risk for sustained ventricular arrhythmias (p = 0.05) than the 20 patients without late potentials. RVEF was the most powerful predictor of late potentials (p = 0.004) at multivariate analysis. Moreover, RVEF < or = 50% was associated with an increased risk for development of sustained ventricular arrhythmias (p = 0.02). A SAECG parameter, namely the root-mean-square voltage of the terminal 40 ms at 25 Hz, was an independent predictive factor for the occurrence of sustained ventricular arrhythmias (p = 0.02). Although fibrous tissue may contribute to delayed myocardial activation in ARVC, a reduced RVEF plays an essential role for spontaneous manifestation of sustained ventricular arrhythmias.

Entities:  

Mesh:

Year:  1999        PMID: 10215287     DOI: 10.1016/s0002-9149(99)00062-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations.

Authors:  Thomas Herren; Philipp A Gerber; Firat Duru
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

2.  Risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  M Silvano; D Corrado; J Köbe; G Mönnig; C Basso; G Thiene; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-10-11

3.  Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.

Authors:  Shuanglun Xie; Benoit Desjardins; Maciej Kubala; Jackson Liang; Jiandu Yang; Rob J van der Geest; Robert Schaller; Michael Riley; David Callans; Erica Zado; Francis Marchlinski; Saman Nazarian
Journal:  Heart Rhythm       Date:  2018-03-02       Impact factor: 6.343

Review 4.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy: new avenues for diagnosis and treatment.

Authors:  E E van der Wall; M Bootsma; H J J Wellens; J J Bax; A de Roos; M J Schalij
Journal:  Neth Heart J       Date:  2003-01       Impact factor: 2.380

5.  Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Ganesh S Kamath; Wojciech Zareba; Jessica Delaney; Jayanthi N Koneru; William McKenna; Kathleen Gear; Slava Polonsky; Duane Sherrill; David Bluemke; Frank Marcus; Jonathan S Steinberg
Journal:  Heart Rhythm       Date:  2010-10-08       Impact factor: 6.343

6.  Fourier phase analysis of SPECT equilibrium radionuclide angiography in symptomatic patients with mitral valve prolapse without significant mitral regurgitation: assessment of biventricular functional abnormalities suggesting a cardiomyopathy.

Authors:  D Casset-Senon; D Babuty; L Philippe; L Fauchier; V Eder; J P Fauchier; J M Pottier; C Delhomme; P Cosnay
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

7.  Correlation between the parameters of signal-averaged ECG and two-dimensional echocardiography in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Yongwhi Park; Yongkeun Cho; Dong-Yeub Lee; Gui-Lyen Jang; Hyunsang Lee; Dong Heon Yang; Hun-Sik Park; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

Review 8.  Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Pietro Turrini; Domenico Corrado; Cristina Basso; Andrea Nava; Gaetano Thiene
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 9.  Utility of SAECG in arrhythmogenic right ventricle dysplasia.

Authors:  Khurram Nasir; Julie Rutberg; Harikrishna Tandri; Ronald Berger; Gordon Tomaselli; Hugh Calkins
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 10.  Multimodality imaging predictors of sudden cardiac death.

Authors:  Fancesco Bandera; Lilit Baghdasaryan; Giulia Elena Mandoli; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.